Nu-Med Plus Accelerates FDA Submission in Light of Patent Ruling
September 10, 2019 08:00 ET
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA...
Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market
August 14, 2018 09:00 ET
|
Nu-Med Plus Inc.
Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products SALT LAKE CITY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a...